Macerich enters the back half of June with a contradictory setup: shorts retreated through last week, but options traders are now the most cautious they have been in months, and the stock shed 5.3% in a single session on Monday.
The sharpest signal this week is in the options market. The put/call ratio has jumped to 0.98, more than two standard deviations above its 20-day average of 0.82 — the highest defensive reading since at least the start of the year. That is a notable reversal from the more bullish PCR readings that accompanied the rally documented in the June 10 note. Something shifted in the options market around June 12-15 when the PCR vaulted from the low-to-mid 0.69 range up through 0.98; demand for downside protection is now running at an extreme relative to recent history.
Short interest tells a less straightforward story. The headline number fell 31% in a single session on June 16, dropping to 5.8% of the free float — approximately 14.9 million shares. At face value, that looks like continued covering from the peak above 6% earlier in the month. The caution is that short interest had actually re-built to 21.4 million shares on June 15 before the sharp drop. That intraday swing is large enough to suggest the estimate is reflecting a data settlement rather than a clean directional trend. Looking at the broader arc, shorts remain well above May levels near 3.5% of the float, so the covering story from the prior note has not fully resolved. Borrow conditions stay loose: availability is ample at 656% of short interest, and cost to borrow is a negligible 0.44%. There is no squeeze pressure in the lending market.
The Street has been moving in a clearly positive direction. JP Morgan upgraded MAC to Neutral from Underweight on June 17, lifting its target to $25 from $23. That follows a Deutsche Bank upgrade to Buy earlier this month and a cluster of target raises from Keybanc, Ladenburg Thalmann, and others — nearly every change in the past month has been upward. The mean price target sits at $23.81, roughly in line with the current price of $23.75, which means the consensus is essentially pricing in no upside from here. Goldman Sachs is the lone holdout, maintaining a Sell with a $19 target. The analyst recommendation divergence factor scores in the 95th percentile — meaning the gap between the most bullish and most bearish views is wider than almost all peers in the sector. Bulls point to recovering mall traffic and leasing momentum; bears flag the REIT's leverage and a PE ratio so deep in negative territory (the stock is not earning through to net income) that traditional valuation anchors are hard to apply. EV/EBITDA has compressed about 1.3 turns over the past 30 days to roughly 16.9x, which is the cleaner valuation lens here.
Among mall REIT peers, the Monday selloff looks isolated to MAC. SPG fell just 0.2% on the day and added 1.6% on the week. SKT slipped 0.6% on Monday but was up 2.3% on the week. FRT was also softer, down 1.1% on the day. The peer context suggests the Monday drop in MAC was stock-specific rather than a sector-wide move — which makes the catalyst question more pointed.
The next hard catalyst is Q2 earnings on August 5. Recent prints have produced muted initial reactions — the last two saw the stock dip under 1% on the day, then recover 2-4% over five sessions. The more relevant question heading into that date is whether the options-market defensiveness that appeared this week reflects new information about leasing trends or the retailer outlook, or simply late hedging after the stock's 10% run earlier in the month. The JP Morgan upgrade landing the same day as a 5% drop makes the picture worth watching closely.
See the live data behind this article on ORTEX.
Open MAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
